Jiangsu Hengrui Medicine Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Hengrui Medicine Co Ltd with three other
companies in this sector in China:
Humanwell Healthcare Group Co Ltd
sales of 15.45 billion Chinese Renmimbi [US$2.46 billion]
Harbin Pharmaceutical Group Company Limited
(12.02 billion Chinese Renmimbi [US$1.92 billion]
of which 66%
was Medicine Trade), and
Beijing Tongrentang Co., Ltd.
(13.36 billion Chinese Renmimbi [US$2.13 billion]
of which 52%
was Retail Operation).
During the year ended December of 2017, sales at
Jiangsu Hengrui Medicine Co Ltd were 13.84 billion Chinese Renmimbi (US$2.21 billion).
increase of 24.7%
versus 2016, when the company's sales were 11.09 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jiangsu Hengrui Medicine Co Ltd
(and since 2012, sales have increased a total of 155%).
Sales of Medicinal Manufacturing saw an increase
24.8% in 2017, from
11.08 billion Chinese Renmimbi to 13.82 billion Chinese Renmimbi.
Not all segments of Jiangsu Hengrui Medicine Co Ltd experienced an increase in sales in 2017:
sales of Other Businesses fell 35.0% to 11.56 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).